XML 46 R28.htm IDEA: XBRL DOCUMENT
v3.25.1

Related Party Transactions (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Related Party Transactions [Abstract] |
Schedule of Due To: PA Vmed Inc | The aggregate Due To: PAVmed Inc. for the period indicated is summarized as follows: Schedule of Due To: PA Vmed Inc
|  | MSA Fees |  |  | Employee-Related Costs |  |  | PAVmed Inc. OBO Payments |  |  | Total |
Balance - December 31, 2022 |  | $ | 1,650 |  |  | $ | 3,026 |  |  | $ | 284 |  |  | $ | 4,960 |
MSA fees |  |  | 9,000 |  |  |  | — |  |  |  | — |  |  |  | 9,000 |
ERC - Payroll & Benefits |  |  | — |  |  |  | 1,828 |  |  |  | — |  |  |  | 1,828 |
On Behalf Of (OBO) activities |  |  | — |  |  |  | — |  |  |  | 1,035 |  |  |  | 1,035 |
Cash payments to PAVmed Inc. |  |  | (4,500 | ) |  |  | (1,691 | ) |  |  | (1,293 | ) |  |  | (7,484 | )
Balance - December 31, 2023 |  | $ | 6,150 |  |  | $ | 3,163 |  |  | $ | 26 |  |  | $ | 9,339 |
|  | MSA Fees |  |  | Employee-Related Costs |  |  | PAVmed Inc. OBO Payments |  |  | Total |
Balance - December 31, 2023 |  | $ | 6,150 |  |  | $ | 3,163 |  |  | $ | 26 |  |  | $ | 9,339 |
MSA fees |  |  | 11,300 |  |  |  | — |  |  |  | — |  |  |  | 11,300 |
ERC - Benefits |  |  | — |  |  |  | 1,888 |  |  |  | — |  |  |  | 1,888 |
On Behalf Of (OBO) activities |  |  | — |  |  |  | — |  |  |  | 779 |  |  |  | 779 |
Cash payments to PAVmed Inc. |  |  | (15,800 | ) |  |  | (2,026 | ) |  |  | (805 | ) |  |  | (18,631 | )
Payment to PAVmed Inc. settled in LUCD stock |  |  | (1,650 | ) |  |  | (3,025 | ) |  |  | — |  |  |  | (4,675 | )
Balance - December 31, 2024 |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Schedule of MSA Fee Expense Classification in Statements of Operations | The MSA Fee expense classification in the consolidated statement of operations for the periods noted is as follows: Schedule of MSA Fee Expense Classification in Statements of Operations
|  | Years Ended December 31, |
|  | 2024 |  |  | 2023 |
Sales & Marketing |  | $ | 581 |  |  | $ | 436 |
General & Administrative |  |  | 8,113 |  |  |  | 6,350 |
Research & Development |  |  | 2,606 |  |  |  | 2,214 |
Total MSA Fee |  | $ | 11,300 |  |  | $ | 9,000 |

X
- Definition Schedule of Due to Parent [Table Text Block] + References No definition available. + Details
Name: | LUCD_ScheduleOfDueToParentTableTextBlock
Namespace Prefix: | LUCD_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph a -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RelatedPartyTransactionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration